Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in KoreaJin Myoung Seok, Ju‐Hong Min, Joong‐Yang Cho et al.|Multiple Sclerosis Journal|2017Cited by 82
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrumSu Yeon Park, Young Nam Kwon, Sun‐Young Kim et al.|Journal of Neurology Neurosurgery & Psychiatry|2023Cited by 18
Comparison of MOG and AQP4 antibody seroprevalence in Korean adults with inflammatory demyelinating CNS diseasesJae‐Won Hyun, Ho Jin Kim, Hye Lim Lee et al.|Multiple Sclerosis Journal|2020Cited by 14
Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective StudyHee Jo Han, Ha Young Shin, Seung Woo Kim et al.|Journal of Korean Medical Science|2024Cited by 2
Potential prognostic value of rheumatoid factor in anti-aquaporin 4-immunoglobin G-positive neuromyelitis optica spectrum disordersHye Lim Lee, Jin Myoung Seok, Soon-Young Hwang et al.|Journal of the Neurological Sciences|2024Cited by 2